• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

踏跳 - 以及超越。

Leadhopping - and beyond.

机构信息

Tripos, Inc., 2935 East Rodeo Park Drive, Santa Fe, NM 87505, USA.

出版信息

Expert Opin Drug Discov. 2006 Sep;1(4):311-21. doi: 10.1517/17460441.1.4.311.

DOI:10.1517/17460441.1.4.311
PMID:23495902
Abstract

Structural novelty has depended for its discovery on a combination of experimental and virtual screening, where virtual screening has meant either docking into a receptor or pharmacophoric or two-dimensional similarity. In this review, leadhopping denotes a new, far more convenient and apparently quite as effective, set of virtual screening methods, all of which emphasise a much more detailed similarity in ligand shape than the pharmacophore approach. Furthermore, some of these leadhopping methods have been adapted to address much broader needs, such as accelerated and simplified lead optimisation, access to an unprecedented vast structural space, and even useful forecasts of off-target pharmacological effects in humans. These methods seem robust and automatable enough to be used directly by laboratory chemists.

摘要

结构新颖性的发现依赖于实验和虚拟筛选的结合,其中虚拟筛选意味着要么对接受体,要么基于药效基团或二维相似性。在这篇综述中,leadhopping 表示一套新的、更方便、显然同样有效的虚拟筛选方法,这些方法都强调配体形状的更详细相似性,而不是药效基团方法。此外,这些 leadhopping 方法中的一些已经被改编,以满足更广泛的需求,如加速和简化先导化合物优化,获得前所未有的广阔结构空间,甚至对人类中潜在的非靶标药理作用进行有用的预测。这些方法似乎足够稳健和自动化,可以直接由实验室化学家使用。

相似文献

1
Leadhopping - and beyond.踏跳 - 以及超越。
Expert Opin Drug Discov. 2006 Sep;1(4):311-21. doi: 10.1517/17460441.1.4.311.
2
Protein flexibility in ligand docking and virtual screening to protein kinases.用于蛋白激酶的配体对接和虚拟筛选中的蛋白质柔性
J Mol Biol. 2004 Mar 12;337(1):209-25. doi: 10.1016/j.jmb.2004.01.003.
3
Predicting multiple ligand binding modes using self-consistent pharmacophore hypotheses.使用自洽药效团假设预测多种配体结合模式。
J Chem Inf Model. 2009 Sep;49(9):2116-28. doi: 10.1021/ci900199e.
4
Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols.生物胺结合型G蛋白偶联受体的虚拟筛选:基于蛋白质和基于配体的虚拟筛选方案的比较评估。
J Med Chem. 2005 Aug 25;48(17):5448-65. doi: 10.1021/jm050090o.
5
Beyond the virtual screening paradigm: structure-based searching for new lead compounds.超越虚拟筛选范式:基于结构寻找新的先导化合物。
J Chem Inf Model. 2009 Apr;49(4):800-9. doi: 10.1021/ci9000212.
6
Novel technologies for virtual screening.虚拟筛选的新技术。
Drug Discov Today. 2004 Jan 1;9(1):27-34. doi: 10.1016/S1359-6446(04)02939-3.
7
Discovery of novel Bruton's tyrosine kinase inhibitors using a hybrid protocol of virtual screening approaches based on SVM model, pharmacophore and molecular docking.基于 SVM 模型、药效基团和分子对接的混合虚拟筛选方法发现新型布鲁顿酪氨酸激酶抑制剂。
Chem Biol Drug Des. 2012 Sep;80(3):366-73. doi: 10.1111/j.1747-0285.2012.01415.x. Epub 2012 Jun 27.
8
Novel approach to structure-based pharmacophore search using computational geometry and shape matching techniques.一种使用计算几何和形状匹配技术进行基于结构的药效团搜索的新方法。
J Chem Inf Model. 2008 Apr;48(4):889-901. doi: 10.1021/ci700368p. Epub 2008 Apr 9.
9
[Research progress of virtual screening aided drug discovery].[虚拟筛选辅助药物发现的研究进展]
Yao Xue Xue Bao. 2009 Jun;44(6):566-70.
10
Comparison of ligand- and structure-based virtual screening on the DUD data set.基于配体和结构的虚拟筛选在DUD数据集上的比较。
J Chem Inf Model. 2009 Feb;49(2):209-31. doi: 10.1021/ci800303k.

引用本文的文献

1
Identification of novel anthrax toxin countermeasures using in silico methods.利用计算机模拟方法鉴定新型炭疽毒素应对措施。
Methods Mol Biol. 2013;993:177-84. doi: 10.1007/978-1-62703-342-8_12.
2
Identification of novel non-hydroxamate anthrax toxin lethal factor inhibitors by topomeric searching, docking and scoring, and in vitro screening.通过拓扑搜索、对接和评分以及体外筛选鉴定新型非羟肟酸炭疽毒素致死因子抑制剂。
J Chem Inf Model. 2009 Dec;49(12):2726-34. doi: 10.1021/ci900186w.